Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Stock Report

| More

HIKAL Ltd Q1FY21 consolidated PAT at Rs. 15 crore

Posted On: 2020-08-04 03:56:53

HIKAL LTD. has reported financial results for the period ended June 30, 2020.

Financial Results (Q1 FY 2020-21) - QoQ Comparison

The company has reported total income of Rs.353.41 crores during the period ended June 30, 2020 as compared to Rs.380.72 crores during the period ended March 31, 2020.

The company has posted net profit / (loss) of Rs.15 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.24.47 crores for the period ended March 31, 2020.

The company has reported EPS of Rs.1.22 for the period ended June 30, 2020 as compared to Rs.1.98 for the period ended March 31, 2020.

FinancialsQ1 FY2020-21Q4 FY19-20% Change
Total Income₹ 353.41 crs₹ 380.72 crsDown Tick -7.17%
Net Profit₹ 15 crs₹ 24.47 crsDown Tick -38.7%
EPS₹ 1.22₹ 1.98Down Tick -38.38%

Financial Results (Q1 FY 2020-21) - YoY Comparison

The company has reported total income of Rs.353.41 crores during the period ended June 30, 2020 as compared to Rs.403.84 crores during the period ended June 30, 2019.

The company has posted net profit / (loss) of Rs.15 crores for the period ended June 30, 2020 as against net profit / (loss) of Rs.25.23 crores for the period ended June 30, 2019.

The company has reported EPS of Rs.1.22 for the period ended June 30, 2020 as compared to Rs.2.05 for the period ended June 30, 2019.

FinancialsQ1 FY2020-21Q1 FY2019-20% Change
Total Income₹ 353.41 crs₹ 403.84 crsDown Tick -12.49%
Net Profit₹ 15 crs₹ 25.23 crsDown Tick -40.55%
EPS₹ 1.22₹ 2.05Down Tick -40.49%

Commenting on the results, Jai Hiremath, Chairman & Managing Director, Hikal Ltd. said, "We started the year with a better than expected performance and I would like to thank all the stakeholders and specially our Employees for standing strong during these difficult times. The revenue in Q1 has been lower by 12% compared to Q1 last year however, with better operational efficiencies we were able to improve our Gross Profit Margins. Our operations were at sub-optimal levels due to the nationwide lockdown and our fixed costs were greater due to the Pandemic which were not absorbed fully thereby impacting our operating profit margins. The performance for the quarter has been impacted by a COVID expense of Rs. 4.7 crore towards employee benefits and other additional costs incurred to mitigate the effect of the pandemic and help society at large.

Our Crop Protection Division saw a revenue dip of 30% in Q1 as compared to corresponding period last year mainly due to several headwinds faced by our global customers which resulted in deferment of volume off-take. Restrictions imposed by State Government in Maharashtra where both our crop protection plants are located also led to lower production and sales. Our Pharmaceutical Division has reported a growth of 5% in top line led by improved capacity ramp-up and better volume off-take by customers.

Looking forward, we are witnessing improvement in capacity utilization and higher volume off-take by our customers for both our divisions. We continue to be positive on growth prospects of both the divisions based on the new opportunities arising due to supply chain de-risking strategy of our customers.

We continue to work on various cost and efficiency improvement initiatives which has already started to show results with improvements in Gross Margins over the last year. We are going ahead with our Capex plans which has been delayed due to the Pandemic and the new capacity is expected to be commissioned between March and June 2021.

As the COVID-19 pandemic situation continues to be volatile and with intermittent lockdowns potentially impacting our operations, therefore at this juncture estimating the performance for the current year is difficult. However, with new capacity coming on stream in early part of next financial year along with normalization of COVID-19 related disruption we will be able to capitalize on our strong customer relationships, new customer inquiries, a healthy product pipeline and new opportunities under "Atmanirbhar Bharat."

Shares of HIKAL LTD. was last trading in BSE at Rs.136.1 as compared to the previous close of Rs. 161.45. The total number of shares traded during the day was 492732 in over 7870 trades.

The stock hit an intraday high of Rs. 167 and intraday low of 132.6. The net turnover during the day was Rs. 71950100.

Source: Equity Bulls

Click here to send ur comments or to

Other Headlines:

Vedanta Ltd board to announce Q1 results on Oct 3, 2020

SBI announces celebratory delights for retail customers

IRCON supported the promotion of culture and heritage by carrying out beautification work on the walls of Bengaluru Railway Station

Chembond Water receives 2020 Best Practices Award from Frost & Sullivan

Symphony introduces world's 1st 'Universal packaged air coolers' for industrial and commercial application

Central Bank of India raises Rs. 254.99 crore through QIP

Refex Industries Ltd to invest in units of RKG Fund - I

Endurance Technologies Ltd board to approve Q2, H1 FY2021 results on Nov 10, 2020

Western Union International Money Transfer Services now available at Alankit Forex India Ltd

Cosmo Films Launches BOPP-Fragranced Packaging Film

India Grid Trust completes acquisition of Jhajjar KT Transco Private Limited

Dhunseri Tea & Industries Ltd enters into MoU for sale of Khetojan Tea Estate

Anuh Pharma Ltd receives approval from WHO for Pyrimcthamine API

Dr Lalchandani Labs Ltd announces increase in capacity for Covid-19 RT-PCR testing

SBI announcement of processing fees waiver on Home Loan

EdgeVerve and Minit Partner to Deliver Actionable Process Intelligence

TCS Wins Four Stevie® Awards at the 2020 International Business Awards

SJVN Limited gets investment approval of 210 MW Luhri HEP and 66 MW Dhaulasidh HEP in Himachal Pradesh

TV Today Network Ltd board to consider Q2, H1 FY2020-21 results on Nov 6, 2020

Pre book with Tanishq and secure your gold rate today

NELCAST Ltd completes Phase II of iron casting project at Pedapariya in Andhra Pradesh

Infosys and Roland-Garros Empower Players, Fans and Media with New Digital Innovations on Court and at Home

Lupin launches Fosaprepitant for Injection

AXIS Bank Ltd board to consider Q2FY21 results on Oct 28, 2020

Ratnamani Metals & Tubes Ltd receives domestic order of Rs. 216 crores in Carbon Steel Division

Gulf Oil Lubricants India Limited announces strategic lubricants partnership with S-Oil Corporation of South Korea

ICRA downgrades rating of TajGVK Hotels & Resorts Limited

ICRA reaffirms rating of NGL Fine-Chem Ltd

TCS iON Opens its National Qualifier Test to All Corporates

Hexaware Becomes a Microsoft Azure Expert Managed Service Provider (MSP) and Earns Advanced Certification for Data Warehouse Migration to Azure

Lupin Launches Atorvastatin Calcium Tablets USP

GlaxoSmithKline Pharmaceuticals Ltd board to announce Q2 results on Oct 28, 2020

IndiGo to shift flights with series 2000 (6E2000-6E2999) from Terminal 3 to Terminal 2 of IGI Airport

Gateway Distriparks Ltd announces change in KMP

Thomas Cook India and SOTC announce the launch of a unique Customer Loyalty Program - Priority

Gateway Distriparks Limited board approves interim dividend of Rs. 2 for FY2020-21

L&T Technology Services Selected to Support Tenneco DRiV™ Ride Performance Division

Surya Roshni Ltd bags orders of Rs. 272.86 crore

RBI approves appointment of interim committee to govern Lakshmi Vikas Bank Limited

Dr. Reddy's Laboratories Ltd board to consider Q2, H1FY21 results on Oct 28, 2020

Lakshmi Vilas Bank clarifies on governance of the bank

Mukand Ltd executes term loan agreement for availing unsecured term loan

Reliance Power appoints Shri Bimal Julka, Shri Vijay Kumar Sharma and Smt. Chhaya Virani as Independent Directors

CARE downgrades rating of CMI Ltd to default grade

Deepak Fertilisers board to consider allotment of 2nd tranche of FCCBs on Sep 30, 2020

CEAT signs Aamir Khan as brand ambassador

Dr. Reddy's Laboratories launches Dimethyl Fumarate Delayed-Release Capsules in the U.S. Market

Narayana Hrudayalaya Ltd's subsidiary registers branch in St. Lucia

Indoco launches FEVINDO 400 - Favipiravir 400mg Tablets

Tata Steel acquires 34,92,500 Equity Shares of Tata Metaliks Ltd on conversion of warrants

Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019